These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1090415)

  • 1. A double-blind study in hypertensive patients of an original new compound, indapamide.
    Witchitz S; Kamoun A; Chiche P
    Curr Med Res Opin; 1975; 3(1):1-8. PubMed ID: 1090415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive activity of a new agent, indapamide: a double-blind study.
    Milliez P; Tcherdakoff P
    Curr Med Res Opin; 1975; 3(1):9-15. PubMed ID: 1090418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the activity of a new agent, indapamide, in essential arterial hypertension.
    Hatt PY; Leblond JB
    Curr Med Res Opin; 1975; 3(3):138-44. PubMed ID: 1097194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
    Schaller MD; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of indapamide in the treatment of hypertension.
    Anavekar SN; Ludbrooke A; Louis WJ; Doyle AE
    J Cardiovasc Pharmacol; 1979; 1(4):389-94. PubMed ID: 94616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
    Plante GE; Dessurault DL
    Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol.
    Zacharias FJ
    Postgrad Med J; 1981; 57 Suppl 2():51-2. PubMed ID: 7033947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indapamide in hypertension: results of a French multi-centre study in ambulant subjects.
    Mimran A; Zambrowski JJ; Coppolani T
    Curr Med Res Opin; 1983; 8 Suppl 3():105-8. PubMed ID: 6352182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes.
    Raggi U; Palumbo P; Moro B; Bevilacqua M; Norbiato G
    Hypertension; 1985; 7(6 Pt 2):II157-60. PubMed ID: 4077234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide.
    Elliott WJ; Weber RR; Murphy MB
    J Clin Pharmacol; 1991 Aug; 31(8):751-7. PubMed ID: 1880234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre open trial indapamide in general practice.
    Bowker CH; Murphy MA
    Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effects of nifedipine and indapamide in the treatment of arterial hypertension].
    Chaignon M; Lucsko M; Rapoud JP; Aubert P; Guédon J
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():67-72. PubMed ID: 3937509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.